1. Metabolische und mentale Folgen der Pandemie
   Charlotte Steenblock et al, 2022, Diabetes aktuell CrossRef
2. The interface of COVID-19, diabetes, and depression
   Charlotte Steenblock et al, 2022, Discov Ment Health CrossRef
3. Metabolomics Based on Peripheral Blood Mononuclear Cells to Dissect the Mechanisms of Chaigui Granules for Treating Depression
   Dehua Huang et al, 2022, ACS Omega CrossRef
4. Anxiety, Depression, and Other Emotional Disorders during the COVID-19 Pandemic: A Narrative Review of the Risk Factors and Risk Groups
   Polina Kassaeva et al, 2022, Encyclopedia CrossRef
5. The Development of GABAergic Network in Depression in Recent 17 Years: A Visual Analysis Based on CiteSpace and VOSviewer
   Jieping Lin et al, 2022, Front. Psychiatry CrossRef
6. SperoPredictor: An Integrated Machine Learning and Molecular Docking-Based Drug Repurposing Framework With Use Case of COVID-19
   Faheem Ahmed et al, 2022, Front. Public Health CrossRef
7. The treatment of depression — searching for new ideas
   Katarzyna Stachowicz et al, 2022, Front. Pharmacol. CrossRef
8. Predictors of personal depression stigma in medical students in China: differences in male and female groups
   Lei Qiu et al, 2022, Medical Education Online CrossRef
9. The comparison of sex differences in depression-like behaviors and neuroinflammatory changes in a rat model of depression model induced by chronic stress
   Juan Xia et al, 2023, Front. Behav. Neurosci. CrossRef
10. O USO DE ANTIDEPRESSIVOS E O RISCO AUMENTADO DE SUICÍDIO/AUTOCÍDIO: uma revisão de literatura
    Marco Antônio Pinto Coutinho et al, 2023, Psicodebate CrossRef
11. Construction of antibiotic-induced depression mice model and the function of intestinal microbiota
    Handan Deng et al, 2023, Front. Microbiol. CrossRef
12. Некоторые психосоциальные феномены, возникшие в период пандемии COVID-19  Some Psychosocial Phenomena that Arose During the COVID-19 Pandemic
    Е. Белова et al, 2023, ВкА CrossRef
13. 1-(Phenylselanyl)-2-(p-tolyl)indolizine: A selenoindolizine with potential antidepressant-like activity in mice mediated by the modulation of dopaminergic and noradrenergic systems
    Marcia Juciele da Rocha et al, 2024, Brain Research CrossRef
14. Dopaminergic Modulation and Computational ADMET Insights for the Antidepressant-like Effect of N-(3-(Phenylselanyl)prop-2-yn-1-yl)benzamide
    Evelyn Mianes Besckow et al, 2024, ACS Chem. Neurosci. CrossRef
15. Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Citalopram and Duloxetine: An Integrated Analytical, Computational, Behavioral, and Biochemical Approach
    Mohamed S. Elgawish et al, 2024, ACS Pharmacol. Transl. Sci. CrossRef